Review: CD154-CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 46, Issue 6, 2002, Pages 1417-1429

  Grammer, Amrie C ^a   Lipsky, Peter E ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; DNA ANTIBODY; DOUBLE STRANDED DNA; IMMUNOGLOBULIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANTIBODY PRODUCING CELL; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; LUPUS ERYTHEMATOSUS; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; CYTOLOGY; IMMUNOLOGY; METABOLISM;

ANTIGENS, CD40; CD40 LIGAND; CELL DIFFERENTIATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PLASMA CELLS;

EID: 0035983744     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10287     Document Type: Review

References (120)

1. Abnormalities in B cell activity and the immunoglobulin repertoire in human systemic lupus erythematosus
2. Autoimmune diseases
3. Systemic lupus erythematosus: An autoimmune disease of B cell hyperactivity
4. Delineating the genetic basis of systemic lupus erythematosus
5. CD40-mediated regulation of immune responses by TRAF-dependent and TRAF-independent signaling mechanisms
6. The CD40 ligand expressed by human B cells costimulates B cell responses
7. Expression, regulation, and function of B cell-expressed CD154 in germinal centers
8. Expression profiling in knockout mice: Lymphotoxin versus tumor necrosis factor in the maintenance of splenic microarchitecture
9. Role of TNF ligand and receptor family in the lymphoid organogenesis defined by gene targeting
10. Immune cell signaling in lupus
11. Plasma cells: Finding new light at the end of B cell development
12. Comparative characteristics of mu chain and alpha chain transcripts expressed by individual tonsil plasma cells
13. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function
14. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway
15. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice
16. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
17. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations
18. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development
19. Role of cyclin kinase inhibitor p21 in systemic autoimmunity
20. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease
21. Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families
22. Genome scan of human systemic: Lupus erythematosus by regression modeling: Evidence of linkage and epistasis at 4p16-15.2
23. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families
24. Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African-American pedigrees
25. The 8.5-kb PstI allele of the stress protein gene, Hsp70-2: An independent risk factor for systemic lupus erythematosus in African Americans?
26. Lack of association between the polymorphism at the heat-shock protein (HSP70-2) gene and systemic lupus erythematosus (SLE) in the Mexican mestizo population
27. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response
28. Studies of the humoral immune response
29. Germinal center reaction
30. The immune response in adenoids and tonsils
31. Cellular interaction in germinal centers: Roles of CD40 ligand and B7-2 in established germinal centers
32. Role of CD154 in the secondary immune response: The reduction of pre-existing splenic germinal centers and anti-factor VIII inhibitor titer
33. Spontaneous formation of germinal centers in autoimmune mice
34. Normalization of peripheral B cells following treatment of active SLE patients with humanized anti-CD154 (5c8, BG9588)
35. Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus
36. Enhanced mutational activity of Vkappa gene rearrangements in systemic lupus erythematosus
37. Enhanced mutational activity and disturbed selection of mutations in V(H) gene rearrangements in a patient with systemic lupus erythematosus
38. Perturbations in the impact of mutational activity on Vlambda genes in systemic lupus erythematosus
39. Regulation and expression of CD154/CD40-ligand on B cells in normal and autoimmune humoral responses
40. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis
41. CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB × NZW)F1 lupus-prone mice: Phenotype and possible role in autoreactivity
42. Peripheral blood lymphocytes in SLE: Hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells
43. CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus
44. Alpha beta T cell regulation and CD40 ligand dependence in murine systemic autoimmunity
45. Circulating and mitogen-induced immunoglobulin-secreting cells in human peripheral blood: Evaluation by a modified reverse hemolytic plaque assay
46. The role of B cell proliferation in the generation of immunoglobulin-secreting cells in man
47. Generation of nondividing high rate Ig-secreting plasma cells in cultures of human B cells stimulated with anti-CD3-activated T cells
48. Independent expression of autoantibodies in systemic lupus erythematosus
49. Cyclophosphamide use in a young woman with antiphospholipid antibodies and recurrent cerebrovascular accident
50. Systemic immune activation and generation of new autoantibodies are features of a SLE flare after remission induced by autologous stem cell transplantation
51. OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development
52. Bcmd governs recruitment of new B cells into the stable peripheral B cell pool in the A/WySnJ mouse
53. NFATc1 and NFATc2 together control both T and B cell activation and differentiation
54. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice
55. Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells
56. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus
57. Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies
58. The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development
59. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF
60. Regulation of the T-independent humoral response by TACI
61. Activation and accumulation of B cells in TACI-deficient mice
62. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire
63. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate
64. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals
65. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help
66. Signaling through TNF receptor p55 in TNF-alpha-deficient mice alters the CXCL13/CCL19/CCL21 ratio in the spleen and induces maturation and migration of anergic B cells into the B cell follicle
67. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC
68. Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients
69. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome
70. Regulation of anti-double-stranded DNA B cells in nonauto-immune mice: Localization to the T-B interface of the splenic follicle
71. Altered selection processes of B lymphocytes in autoimmune NZB/W mice, despite intact central tolerance against DNA
72. Unique site of IgG2a and rheumatoid factor production in MRL/1pr mice
73. Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: Changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins
74. Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions
75. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells
76. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus
77. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus
78. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients
79. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans
80. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease
81. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis
82. The FcγRIIIA-158F allele is a risk factor for systemic lupus erythematosus
83. Systemic lupus erythematosus, complement deficiency, and apoptosis
84. Cr2, a candidate gene in the murine sle1c lupus susceptibility locus, encodes a dysfunctional protein
85. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus
86. Phagocytosis and clearance of apoptotic cells is mediated by MER
87. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity
88. Mutation of DNASE1 in people with systemic lupus erythematosus
89. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity
90. Expression of B cell receptor-associated signaling molecules in human lupus
91. Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice
92. Identification of the gene variations in human CD22
93. Hyperex-pression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production
94. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes
95. Do B cells drive the diversification of immune responses?
96. Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: Role of autoimmune T cell receptor alpha chain
97. Evidence for multiple mechanisms of polyclonal T cell activation in murine lupus
98. A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex
99. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis
100. Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells
101. RAG1 and RAG2 expression by B cell subsets from human tonsil and peripheral blood
102. Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells
103. Rearrangement of lambda light chain genes in mature B cells in vitro and in vivo: Function of reexpressed recombination-activating gene (RAG) products
104. Re-expression of RAG-1 and RAG-2 genes and evidence for secondary rearrangements in human germinal center B lymphocytes
105. Antigen receptor engagement turns off the V(D)J recombination machinery in human tonsil B cells
106. Expression of recombination activating genes 1 and 2 in peripheral B cells of patients with systemic lupus erythematosus
107. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk
108. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals
109. The chosen few? Positive selection and the generation of naive B lymphocytes
110. Somatic mutations in the variable regions of a human IgG anti-double-stranded DNA autoantibody suggest a role for antigen in the induction of systemic lupus erythematosus
111. The double edged sword of the immune response: Mutational analysis of a murine anti-pneumococcal, anti-DNA antibody
112. Characterization of two human anti-DNA antibodies bearing the pathogenic idiotype 8.12
113. In vitro stimulation of human tonsillar subepithelial B cells: Requirement for interaction with activated T cells
114. B lymphocyte hyperactivity in families of patients with systemic lupus erythematosus
115. A coordinated change in chemokine responsiveness guides plasma cell movements
116. Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes
117. Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3alpha/CCL20 in human B cells
118. The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus
119. Derivation of the SLEDAI: A disease activity index for lupus patients
120. A short course of BG9588 (anti-CD40L) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis